Therapeutic and pharmacological potential of Tanshinones against lung cancer: A systematic review

Adams, 2019, Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1, Front. Mol. Biosci., 6, 11, 10.3389/fmolb.2019.00011 Ansari, 2021, Prospective therapeutic potential of Tanshinone IIA: an updated overview, Pharmacol. Res., 164, 10.1016/j.phrs.2020.105364 Cao, 2021, Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase, Eur. J. Pharmacol., 890, 10.1016/j.ejphar.2020.173647 Chen, 2014, Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo, Mol. Med. Rep., 9, 2447, 10.3892/mmr.2014.2093 Chen, 2013, The anticancer properties of salvia Miltiorrhiza Bunge (Danshen): a systematic review: the anticancer effects of salvia Miltiorrhiza Bunge, Med. Res. Rev., 34, 768, 10.1002/med.21304 Cheng, 2010, Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential, Mol. Med. Rep., 3, 645 Chiu, 2010, Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential, Int. J. Mol. Med., 25, 231 Gao, 2020, Inhibition of EGFR signaling and activation of mitochondrial apoptosis contribute to tanshinone IIA-mediated tumor suppression in non-small cell lung cancer cells, OncoTargets Ther. Volume, 13, 2757, 10.2147/OTT.S246606 Gao, 2015, Total Tanshinones-induced apoptosis and autophagy via reactive oxygen species in lung cancer 95D cells, Am. J. Chin. Med., 43, 1265, 10.1142/S0192415X1550072X Jiang, 2019, Tanshinones, critical pharmacological components in Salvia miltiorrhiza, Front. Pharmacol., 10, 202, 10.3389/fphar.2019.00202 Jin, 2020, Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm, Chin. Med., 15, 66, 10.1186/s13020-020-00348-4 Jung, 2020, Autophagy as a decisive process for cell death, Exp. Mol. Med., 52, 921, 10.1038/s12276-020-0455-4 Kim, 2016, Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction, Int. J. Oncol., 48, 2205, 10.3892/ijo.2016.3441 Kim, 2018, Cryptotanshinone induces cell cycle arrest and apoptosis of NSCLC cells through the PI3K/Akt/GSK-3β pathway, Int. J. Mol. Sci., 19, 2739, 10.3390/ijms19092739 Leary, 2018, Sensitization of drug resistant cancer cells: a matter of combination therapy, Cancers (Basel), 10, 483, 10.3390/cancers10120483 Li, 2016, Anti-tumor activity of Tanshinone IIA in combined with cyclophosphamide against Lewis mice with lung cancer, Asian Pac. J. Trop. Med., 9, 1084, 10.1016/j.apjtm.2016.09.003 Li, 2013, Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function: Tanshinones and lung cancer, Mol. Carcinog., 52, 535, 10.1002/mc.21888 Liao, 2019, Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway, Phytother. Res., 33, 2298, 10.1002/ptr.6392 Liu, 2012, An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of Tanshinone IIA against non-small cell lung cancer, PLoS ONE, 7 Liu, 2019, Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma, Cancer Immunol. Immunother., 68, 1059, 10.1007/s00262-019-02326-8 Ma, 2015, Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer, Oncotarget, 6, 20111, 10.18632/oncotarget.3933 Man, 2016, Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway, Oncol. Lett., 12, 4094, 10.3892/ol.2016.5123 Qi, 2019, Cryptotanshinone suppresses non-small cell lung cancer via microRNA-146a-5p/EGFR axis, Int. J. Biol. Sci., 15, 1072, 10.7150/ijbs.31277 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J. Clin. caac, 21660 Takeuchi, 2014, Anti-growth activity of Tanshinone IIA towards gefitinib. -Sensitive and -resistant nonsmall cell lung cancer cells, Int. J. Plant Biol. Res., 2, 1020 Tung, 2013, Active component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, attenuates lung Tumorigenesis via inhibitions of VEGF, Cyclin A, and Cyclin B expressions, Evid. Based Complement. Alternat. Med., 1 Uddin, 2021, Non-flavonoids targeting cancer stem cells: a promising therapeutic avenue for cancer treatment Vundavilli, 2020, Cryptotanshinone induces cell death in lung cancer by targeting aberrant feedback loops, IEEE J. Biomed. Health Inform., 24, 2430, 10.1109/JBHI.2019.2958042 Wang, 2019, Cryptotanshinone inhibits lung cancer invasion via microRNA‑133a/matrix metalloproteinase 14 regulation, Oncol. Lett. Wang, 2019, Tanshinone IIA reverses gefitinib-resistance in human non-small-cell lung cancer via regulation of VEGFR/Akt pathway, OncoTargets Ther., 12, 9355, 10.2147/OTT.S221228 Xia, 2015, Cryptotanshinone reverses cisplatin resistance of human lung carcinoma a549 cells through down-regulating Nrf2 pathway, Cell. Physiol. Biochem., 37, 816, 10.1159/000430398 Xie, 2015, The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line, Acta Pharm. Sin. B, 5, 554, 10.1016/j.apsb.2015.07.008 Xie, 2016, Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way, BMC Cancer, 16, 899, 10.1186/s12885-016-2921-x Yan, 2018, Effect and mechanism of Tanshinone I on the radiosensitivity of lung cancer cells, Mol Pharm, 11 Yoo, 2013, Angiogenesis and its therapeutic opportunities, Mediators Inflamm, 2013, 1, 10.1155/2013/127170 Yun, 2018, The roles of autophagy in cancer, Int. J. Mol. Sci., 19, 3466, 10.3390/ijms19113466 Zhang, 2016, Tanshinones suppress non–small cell lung cancer through up-regulating miR-137, Acta Biochim. Biophys. Sin., 48, 768, 10.1093/abbs/gmw053 Zhang, 2014, Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway, Int. J. Oncol., 45, 683, 10.3892/ijo.2014.2471 Zhang, 2018, Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway, Oncol. Rep., 40, 2926